Boothbay Fund Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,488
| Closed | -$1.05M | – | 1731 |
|
|
2024
Q3 | $1.05M | Buy |
3,488
+2,166
| +164% | +$650K | 0.02% | 604 |
|
|
2024
Q2 | $435K | Buy |
+1,322
| New | +$435K | 0.01% | 901 |
|
|
2024
Q1 | – | Sell |
-1,970
| Closed | -$694K | – | 1764 |
|
|
2023
Q4 | $694K | Buy |
1,970
+362
| +23% | +$127K | 0.02% | 727 |
|
|
2023
Q3 | $603K | Buy |
+1,608
| New | +$603K | 0.01% | 798 |
|
|
2023
Q2 | – | Sell |
-4,984
| Closed | -$1.73M | – | 2081 |
|
|
2023
Q1 | $1.73M | Buy |
+4,984
| New | +$1.73M | 0.04% | 616 |
|
|
2022
Q4 | – | Sell |
-3,143
| Closed | -$773K | – | 2179 |
|
|
2022
Q3 | $773K | Buy |
+3,143
| New | +$773K | 0.02% | 889 |
|
|
2021
Q3 | – | Sell |
-1,288
| Closed | -$463K | – | 1979 |
|
|
2021
Q2 | $463K | Buy |
+1,288
| New | +$463K | 0.01% | 912 |
|